Rhys de Callier leads corporate strategy, portfolio management and government relations for QuidelOrtho. He is also a member of the senior executive team, serving as a key partner for organizational leaders across all corporate development initiatives.

Mr. de Callier has nearly 20 years of experience in the in vitro diagnostics industry. He has held several leadership roles at the company including Head of the Point of Care business unit, where he oversaw the commercial launch of the Sofia® Platform. He has also led strategic marketing and business development functions, as well as commercial marketing for North America. Before joining QuidelOrtho in 2006, he worked for Sempra Energy and Sony.

Mr. de Callier earned both his MBA and bachelor’s degree in business administration from Drury University.